Madison Investment Advisors LLC Takes Position in HealthEquity, Inc. (NASDAQ:HQY)

Madison Investment Advisors LLC acquired a new stake in HealthEquity, Inc. (NASDAQ:HQY) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 70,155 shares of the company’s stock, valued at approximately $6,731,000. Madison Investment Advisors LLC owned about 0.08% of HealthEquity at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of HQY. Arcadia Investment Management Corp MI purchased a new position in HealthEquity in the fourth quarter valued at approximately $26,000. Smartleaf Asset Management LLC lifted its stake in HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after purchasing an additional 98 shares during the last quarter. Proficio Capital Partners LLC purchased a new position in HealthEquity in the fourth quarter valued at approximately $39,000. UMB Bank n.a. lifted its position in shares of HealthEquity by 65.6% during the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after acquiring an additional 164 shares in the last quarter. Finally, Skandinaviska Enskilda Banken AB publ lifted its position in shares of HealthEquity by 1,934.8% during the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company’s stock worth $45,000 after acquiring an additional 445 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Insider Activity at HealthEquity

In other news, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the transaction, the director now directly owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.20% of the stock is owned by insiders.

Analyst Ratings Changes

Several equities research analysts have issued reports on HQY shares. Barrington Research increased their target price on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research report on Monday, December 2nd. BTIG Research increased their target price on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research report on Thursday, November 14th. Royal Bank of Canada increased their target price on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 10th. Raymond James increased their target price on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 25th. Finally, JMP Securities increased their target price on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research report on Tuesday, December 10th. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $113.54.

HealthEquity Stock Down 1.9 %

HQY opened at $93.97 on Friday. The stock has a market cap of $8.14 billion, a PE ratio of 86.21, a P/E/G ratio of 1.60 and a beta of 0.62. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $115.59. The business’s fifty day simple moving average is $105.74 and its 200 day simple moving average is $94.94.

HealthEquity (NASDAQ:HQY) last released its earnings results on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the prior year, the firm posted $0.40 earnings per share. As a group, research analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.